Loading clinical trials...
Loading clinical trials...
This study is perform to study the effect of psychological and psychosocial factors associated with resilience to the self-stigmatization of people living with HIV
Epidemiological and sociological survey carried out with patients and their caregivers in the CHUs and CHGs of France via the COREVIH from 01/17/2022 to 02/17/2022. Primary endpoint: Self-stigmatization as experienced by PLWHA will be explored through a patient questionnaire Secondary endpoints:The main explanatory variables will be studied by means of a custom questionnaire intended for the patient and covering psychological flexibility, social provisions, avoidance and fusion mechanisms, quality of life, anxiety and depression. The socio-demographic explanatory variables will be collected by questionnaire, covering the following areas: sex, age, geographical origin, insecurity, drug use, sexuality, family context, employment, leisure, care environment. A questionnaire intended for caregivers will study the self-stigmatization perception of the people they care for and the means implemented to fight against self-stigmatization. Anonymous data will be reported in Redcap. The population will be described by numbers and percentages for categorical variables and by the mean ± standard deviation or the median \[interquartile range\] for the quantitative variables, with regard to their statistical distribution. Normality will be studied by the Shapiro-Wilk test and / or by histogram. As far as possible, graphical representations will be associated with the analyzes.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Centre Hospitalier du Pays d'Aix
Aix-en-Provence, France
Chu Angers
Angers, France
CH Annecy Genevois
Annecy, France
Chru Besancon
Besançon, France
CHRU Brest
Brest, France
CH Cholet
Cholet, France
Hopital Antoine Beclere
Clamart, France
Clermont-Ferrand University Hospital
Clermont-Ferrand, France
Chu Dijon
Dijon, France
Hopital Raymond Poincaré
Garches, France
Start Date
January 17, 2022
Primary Completion Date
April 14, 2022
Completion Date
April 14, 2022
Last Updated
May 1, 2023
667
ACTUAL participants
Lead Sponsor
University Hospital, Clermont-Ferrand
Collaborators
NCT06694805
NCT04142047
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07428330